Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: Patient-reported outcomes from multiple controlled and open-label extension studies

Michael H. Schiff, Elaine B. Yu, Michael E. Weinblatt, Larry W. Moreland, Mark C. Genovese, Barbara White, Amitabh Singh, Yun Chon, J. Michael Woolley

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The impact of long-term therapy for rheumatoid arthritis (RA) in elderly (≥65 years of age) and younger (

Original languageEnglish (US)
Pages (from-to)167-178
Number of pages12
JournalDrugs & Aging
Volume23
Issue number2
DOIs
StatePublished - 2006
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: Patient-reported outcomes from multiple controlled and open-label extension studies'. Together they form a unique fingerprint.

Cite this